FOR MEDICAL PROFESSIONALS

The DermoElectroPoration® System is a Class II FDA cleared biophysical alternative to infuse high weight molecule modalities into the dermis without the use of needles!  DEP Medical is the exclusive North American distributor of  Transderm® Infusion.

DermoElectroPoration® (DEP) is a patented, proprietary technology from Mattioli Engineering. It utilizes the skins water based “channels” to allow ionic drug solutions to penetrate due to controlled “electroporation-like” continuous reversed polarity electrical pulses. Because of this, DermoElectroPoration® is able to control the average pulse value and vary the pulse shape according to the skin’s specific electrical impedance.

DermoElectroPoration® promotes the transdermal delivery of both micro- and macro molecules (up to 2 million Dalton weight) safely into the body without the need of modifying the ionic drug solution pH, as with traditional iontophoresis. DermoElectroPoration® does not require a pH compensation patch, driving gels, or pre-charged ions.
DermoElectroPoration® promotes the transdermal delivery of both micro- and macro molecules (up to 2 million Dalton weight) safely into the body without the need of modifying the ionic drug solution pH, as with traditional iontophoresis. DermoElectroPoration® does not require a pH compensation patch, driving gels, or pre-charged ions.

DEP (DermoElectroPoration®) System is the new non-invasive, stand alone powered drug-delivery system.

DermoElectroPoration® increases the skin’s permeability by using the skin’s water based channels opened by a particular controlled current delivered to the patient, therefore allowing the substances to be absorbed by the hypodermis and muscle membranes.

DEP Medical Inc.

Org chart

Teams

Offices